Five digital health tech startups have received a total of $3.25 million from the Medical Research Future Fund (MRFF) through the ANDHealth+ program.
The funding will support studies and scaling of the startups to tackle various health issues including genomics, gut and metabolic health, immune deficiencies, and improved clinical efficiencies.
The startups, Eugene, Atmo Biosciences, Immunosis, Metabolic Health Solutions, and Humanetix, will utilize the funding to advance their technologies, conduct studies, and improve patient care.
The MRFF funding aims to accelerate the delivery of innovative solutions into the healthcare system and support Australia's digital health opportunity.